Paper30173249
Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
Melincovici CS and 8 others. Rom J Morphol Embryol, 2018. Cited by 1,061 papers, by iCite.
Cite this record
ConductScience Library. Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Papers, record 30173249. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30173249
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Angiogenesis Inhibitors | Major topic |
| Neoplasms | Major topic |
| Vascular Endothelial Growth Factor A | Major topic |
| Animals | |
| Humans | |
| Neovascularization, Pathologic |
Source PubMed
Cited by731
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,061 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42947823 | Global research status and emerging frontiers of Shoutai Wan in the prevention and treatment of spontaneous abortion: a bibliometric analysis (1982-2026). | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42947823 | PubMed |
| 42920650 | Exploratory machine-learning analysis of bevacizumab exposure and circulating VEGF dynamics in patients with cancer. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42920650 | PubMed |
| 42903807 | Reprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity. | Front Immunol | 2026 | https://conductscience.org/library/papers/42903807 | PubMed |
| 42900344 | The interplay of integrin, VE-cadherin, and β-catenin signaling triad in angiogenesis: regulation by Wnt antagonist, secreted frizzled related protein 4 in the tumor angiogenic loop. | Med Oncol | 2026 | https://conductscience.org/library/papers/42900344 | PubMed |
| 42889244 | Targeting vascular endothelial growth factor (VEGF)-induced angiogenesis with Rosa hybrida leaf extract via VEGF receptor-2 signaling and matrix metalloproteinase-2 inhibition. | Nutr Res Pract | 2026 | https://conductscience.org/library/papers/42889244 | PubMed |
| 42800001 | Peripheral non-invasive focused ultrasound alleviates constipation by reducing gastrointestinal inflammation. | Exp Physiol | 2026 | https://conductscience.org/library/papers/42800001 | PubMed |
| 42799204 | Advancements in Functional Polymeric Scaffolds for Scar-Free Skin Regeneration. | Polym Sci Technol | 2026 | https://conductscience.org/library/papers/42799204 | PubMed |
| 42797915 | Modeling Canine Hemangiosarcoma Progression Using Patient-Derived 2.5D Organoids and Orthotopic Xenografts. | Vet Sci | 2026 | https://conductscience.org/library/papers/42797915 | PubMed |
| 42795776 | Aprepitant, a Neurokinin-1 Receptor Antagonist, as a Disruptive Drug for the Treatment of Pediatric Cancer. | J Clin Med | 2026 | https://conductscience.org/library/papers/42795776 | PubMed |
| 42769404 | Effect of Huaier Granules combined with transarterial chemoembolization on recurrence and survival in postoperative hepatocellular carcinoma patients with microvascular invasion. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42769404 | PubMed |
| 42739873 | Prognostic Value of the Lung Immune Prognostic Index and an ECOG-Albumin-LIPI Nomogram in Metastatic NSCLC Patients Treated with Second- or Third-Line Nivolumab. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739873 | PubMed |
| 42727584 | Bi-hourly plasma proteomics during the first 48 h of life in an African cohort reveals distinct periods and sex-dependent immune development. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42727584 | PubMed |
| 42722676 | Insulin-like growth factor receptor signaling in physiology and disease. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42722676 | PubMed |
| 42720689 | Multi-database pharmacovigilance identifies disproportionate reporting of hepatobiliary events with avacopan: an integrative study with network pharmacology and interpretable machine learning. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | https://conductscience.org/library/papers/42720689 | PubMed |
| 42706341 | Neutrophils in cancer. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/42706341 | PubMed |
| 42688884 | Remodeling the Tumor Microenvironment: Mechanistic Insights and Translational Frontiers of TCM-Derived Bioactive Monomers. | Cancer Manag Res | 2026 | https://conductscience.org/library/papers/42688884 | PubMed |
| 42667514 | FAK regulates leptin-induced angiogenesis and vasculogenic mimicry in breast cancer. | Med Oncol | 2026 | https://conductscience.org/library/papers/42667514 | PubMed |
| 42654142 | Multifunctional VEGF/CeO2-Loaded Methacrylated Chitosan Hydrogel Promotes Renal Repair Through Immune-Metabolic Reprogramming and Structural Preservation Following Ischemia-Reperfusion Injury. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654142 | PubMed |
| 42650831 | Senescence and Hypoxia Regulate Colon Cancer Cell Transcriptome and Secretome: Insights into Cancer Cell Senescence Pathophysiology. | Biomolecules | 2026 | https://conductscience.org/library/papers/42650831 | PubMed |
| 42637719 | Dysregulated differentiation kinetics underlie the essential role of DNA damage repair in placental development. | Nat Commun | 2026 | https://conductscience.org/library/papers/42637719 | PubMed |
Genes12
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30173249
GET https://conductscience.org/api/papers/v1/30173249/cited_by?page=2